1. Nitzan U, Lichtenberg P. Questionnaire Survey on use of Placebo. BMJ 2004; 329(7472): 944–946.
2. Nitzan U, Chalamish Y, Krieger I, Erez HB, Braw Y, Lichtenberg P. Suggestibility as a predictor of response to antidepressants: A preliminary prospective trial. J Affect Disord. 2015 Jun 24;185:8-11.
3. Nitzan U, Bekerman T, Becker G, Fennig S, Lichtenberg P, Lev-Ran S, Walter G, Bloch Y.
Physician Perception Regarding Side-Effect Profile at the Onset of Antidepressant Treatment: A Survey of Israeli Psychiatrists and Primary Care Physicians.
Ann Gen Psych, 2016; 15: 5.
4. Feffer K, Lichtenberg P, Becker G, Bloch Y, Netzer R, Nitzan U. A Comparative Study with Depressed Patients on the Acceptability of Placebo Use.
Gen Hosp Psychiatry 2016; 41 (2016) 53–56.
5. Feffer K, Lapidus K, Braw Y, Bloch Y, Maoz H, Kron S, Netzer R, Nitzan U. Depression severity as a predictor of Deep Transcranial Magnetic Stimulation effectiveness in a Real-World Clinical Setting: Results from the First 40 Cases of Treatment-Resistant Depression Eur Psychiatry 2016
6. Nitzan U, Hecht M, Braw Y, Maoz H, Levkovitz Y, Yarnitsky D, Granovsky Y, Bloch Y. Initial Evaluation of Pain Intensity Among Depressed Patients as a Possible Mediator Between Depression and Pain Complaints. Front Psychiatry. 2019 Feb 15;10:48. doi: 10.3389/fpsyt.2019.00048. eCollection .
7. Nitzan U, Chalamish Y, Krieger I, Erez HB, Braw Y, Lichtenberg P. Suggestibility as a predictor of response to antidepressants: A preliminary prospective trial. J Affect Disord. 2015 Jun 24;185:8-11. doi: 10.1016/j.jad.2015.06.028. [Epub ahead of print]
